Based only on the information provided: I wouldn't develop anything beyond (manufacturing) process failure modes effects and analysis. A UFMEA makes no sense (because you are ignorant of user populations and use cases), and
DFMEA (for a component manufacturer) really would only bring benefit if the manufacturer is attempting to be as thorough as possible with respect to the questions "will this component work as expected?" and "could this component work
better?"
I recommend that
as a component manufacturer, you focus your
PFMEA on three areas:
- Process steps be analyzed with respect to elements that can result in non-conforming product (and non-conforming in identified ways)
- Process steps that can result in product with manufacturing materials present on conforming product (e.g. cutting fluid, mold release)
- Process steps that can affect production yield (rates)
The first point is
most of what a medical device manufacturer will want to see, they will understand how this affects the risk profile (per 14971) of their device. You won't know their risk assessments
a priori, but you will know your process.
The second point will also be needed by a medical device manufacturer, but because they won't know your manufacturing process, they wouldn't even think to ask (
a priori). Having this information in your PFMEA will allow them to assess if your controls are necessary and/or adequate.
The third point is to benefit your own business. You may have implemented process controls that have nothing to do with the risk of a finished medical device (to patients/users/stakeholders) but adding/removing/manipulating such controls/process steps could affect your process metrics and a PFMEA is an excellent tool to motivate specific control charts, etc. Your medical device customers won't care about such things, but there is value in PFMEA beyond compliance to 14971.